Reducing dietary fat digestion and absorption by modulating the activity of pancreatic lipase has become a favorable strategy to tackle obesity, not only because pancreatic lipase is the single most important determinant of fat absorption, but targeting pancreatic lipase is also considered safe, as its inhibitors neither act on the central nervous system nor enter the bloodstream. This evidence concerns the gene PNLIP and obesity disorder.